Ongoing treatment(s)-Chemotherapy Posts on Medivizor
Navigation Menu

Ongoing treatment(s)-Chemotherapy Posts on Medivizor

Heart side effects and anthracyline medications – what is the benefit/risk in breast cancer?

Posted by on Jul 16, 2019 in Breast cancer | 0 comments

In a nutshell This study investigated the effectiveness and side effects on the heart of anthracycline-based therapies (ABTs) for breast cancer. They found that non-doxorubicin (non-DXR) ABTs had a better benefit/risk ratio (BRR) than DXR alone.  Some background Anthracycline-based therapies (ABTs) are commonly used to treat breast...

Read More

Evaluating the heart side effects of anthracycline treatment in patients with AML undergoing stem cell transplantation

Posted by on May 26, 2019 in Leukemia | 0 comments

In a nutshell This study evaluated the side effects associated with anthracycline treatment in patients with acute myeloid leukemia (AML) who undergo stem cell transplantation (SCT). This study concluded that anthracycline treatment may impact survival outcomes for these patients after a SCT. Some background Cytarabine (Ara-C) plus an anthracycline...

Read More

High dose vitamin D supplementation may be associated with improved colorectal cancer outcomes

Posted by on May 19, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated if high-dose vitamin D combined with chemotherapy improves outcomes in patients with metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that high-dose vitamin D was associated with an improved chance of survival. Some background Vitamin D is associated with the intake of...

Read More

Do ACE inhibitors help with anthracycline-induced cardiotoxicity in leukemia and lymphoma?

Posted by on Dec 6, 2018 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study aimed to investigate if enalapril influences anthracycline-induced cardiotoxicity in children with leukemia and lymphoma. This study concluded that enalapril has a role in reducing anthracycline-induced cardiotoxicity in these patients. Some background Anthracyclines are a class of chemotherapy drugs that can be used for...

Read More

Adding olanzapine to standard treatments to prevent nausea and vomiting in breast cancer chemotherapy

Posted by on Nov 24, 2018 in Breast cancer | 0 comments

In a nutshell This study wanted to find out if adding a medication called olanzapine (Zyprexa) to the current treatment methods helps reduce vomiting and nausea in patients with breast cancer who are receiving chemotherapy with anthracycline. The study found that adding in olanzapine to standard treatment helped reduce vomiting and nausea compared to...

Read More

Combinations of lenalidomide, fludarabine and rituximab for previously untreated chronic lymphocytic leukemia

Posted by on Nov 19, 2018 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the safety and effectiveness of a combination of lenalidomide (Revlimid), fludarabine (Fludara) and rituximab (Rituxan) in patients with previously untreated chronic lymphocytic leukemia. This study concluded that this combination was effective, but the tolerability varied between...

Read More

Oral mucositis caused by targeted therapy for colorectal cancer: which drug is safer?

Posted by on Nov 4, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the frequency and severity of oral mucositis (OM) in patients with colorectal cancer treated with chemotherapy and panitumumab (Vectibix) or cetuximab (Erbitux). Researchers suggested that panitumumab ?is associated with increased levels of OM in these patients. Some background Colorectal cancer is the fourth...

Read More